Latest PSTI reports update at 2024-02-12: 2023-Q42023-Q22022-Q4
Pluristem Therapeutics  logo

Pluristem Therapeutics PSTI

$ 1.03 -1.9%

Country

israelIsrael

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

CEO

Mr. Yaky Yanay

Employees in the company

146

Shares

36.7 M

Market Cap[1]

$ 33.3 M

EBITDA (LTM)

$ -32.2 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.